Tepadina (Thiotepa)

Tepadina (Thiotepa)  WholeSaler, Distributor, Supplier


Tepadina (Thiotepa) is an alkylating agent used with other medicines in the conditioning regimen before hematopoietic stem cell transplantation (HSCT). 

Indication and Usage: 

  • To reduce the risk of graft rejection when used in conjunction with high-dose busulfan and cyclophosphamide as a preparative regimen for allogeneic hematopoietic progenitor (stem) cell transplantation (HSCT) for pediatric patients with class 3 beta-thalassemia. 
  • For treatment of adenocarcinoma of the breast or ovary.
  • For controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities. 
  • For treatment of superficial papillary carcinoma of the urinary bladder. (Information are based on FDA) 

Side Effects:

Common side effects of Tepadina includes:

  • Increased risk of getting an infection. 
  • Breathlessness and looking pale.
  • Bruising, bleeding gums or nosebleeds. 
  • Tiredness and weakness (fatigue) during and after treatment. 
  • Headaches and dizziness. 
  • Eye problems. 
  • Fits (seizures) .
  • Feeling or being sick.

Dosage form & Strength:

  • Tepadina 100mg/vial WholeSaler
  • Tepadina 15mg/vial Supplier